ニュース

GIGAZINE2 日
mRNAインフルエンザワクチンの効果が従来のワクチンを上回ったと ...
新型コロナウイルスのmRNAワクチンを開発したことで知られる製薬企業のモデルナが、季節性インフルエンザのmRNAワクチン「mRNA-1010」の第3相臨床 ...
ロイター1年
Moderna flu shot succeeds in late-stage study | Reuters
(Reuters) -Moderna on Wednesday said its flu vaccine had generated a stronger immune response against all four A and B strains of the influenza virus compared to traditional flu shots in a late ...
ロイター1月
US cancels over $700 mln funding for Moderna bird flu vaccine
The Trump administration has canceled a contract awarded to Moderna for the late-stage development of its bird flu vaccine for humans, as well as the right to purchase shots, the drugmaker ...